Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EWZ vs MRNA✓SelectedUSD · MRNAEWZ vs MRNA performance historyLatest closeAs of-3.29%11/20
Stock and ETF performance explorer

EWZ vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.5%
MRNA return
-27.3%
Excess return
+71.8%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.3%-2.2%-1.1%-3.2%
7D-11.4%-12.7%+1.3%-11.0%
30D-32.9%-20.7%-12.2%-32.4%
3M-16.4%+46.3%-62.7%-17.7%
6M-21.6%+305.2%-326.8%-28.5%
YTD-9.3%+561.2%-570.6%-20.3%
1Y-6.5%+772.1%-778.6%-19.6%
3Y-0.5%+147.0%-147.4%-9.0%
All+44.5%-27.3%+71.8%+34.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling